Evaluation of Efficacy, Safety and Tolerability of NGM282
(Aldafermin) in a Phase 2b, Randomized, Double-blind,
Placebo-controlled, Multi-center Study in Subjects with
Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (ALPINE
4)
Please contact us for more information or to learn if you are eligible to participate.
